Identification | Back Directory | [Name]
(2-Trifluoromethyl-pyridin-3-yl)-methanol | [CAS]
131747-57-4 | [Synonyms]
2-(Trifluoromethyl)-3-pyridinemethanol 2-(Trifluoromethyl)pyridine-3-methanol 3-pyridineMethanol, 2-(trifluoroMethyl)- (2-Trifluoromethyl-pyridin-3-yl)-methanol | [Molecular Formula]
C7H6F3NO | [MDL Number]
MFCD11100743 | [MOL File]
131747-57-4.mol | [Molecular Weight]
177.12 |
Chemical Properties | Back Directory | [Boiling point ]
209℃ | [density ]
1.362 | [Fp ]
80℃ | [storage temp. ]
Sealed in dry,Room Temperature | [pka]
13.08±0.10(Predicted) | [Appearance]
Light yellow to yellow Solid |
Hazard Information | Back Directory | [Synthesis]
General procedure for the synthesis of (2-trifluoromethyl-pyridin-3-yl)-methanol from ethyl 2-trifluoromethylnicotinate: sodium borohydride (0.35 g, 9.1 mmol) was suspended in anhydrous tetrahydrofuran (20 mL). Anhydrous tetrahydrofuran solution (20 mL) of ethyl 2-trifluoromethylnicotinate (1.00 g, 0.46 mmol) was added dropwise to the stirred suspension under ice bath cooling. The reaction mixture was stirred at 4°C for 16 hours. Upon completion of the reaction, methanol (5 mL) was added to quench the residual sodium borohydride, followed by the addition of 15% aqueous sodium hydroxide solution (25 mL). The resulting mixture was continued to be stirred at 25 °C for 30 min, followed by removal of tetrahydrofuran and methanol by rotary evaporation. The remaining aqueous phase was extracted with ethyl acetate (3 x 25 mL). The organic phases were combined, dried with anhydrous sodium sulfate, filtered and concentrated by rotary evaporation to afford the target product (2-trifluoromethyl-pyridin-3-yl)-methanol as a yellow oil (0.61 g, 75% yield), which could be used in subsequent reactions without further purification. The product was characterized by 1H-NMR (CDCl3): δ 8.64 (d, J = 4.5 Hz, 1H), 8.17 (d, J = 8.0 Hz, 1H), 7.57 (dd, J = 8.0, 4.5 Hz, 1H), 4.98 (s, 2H), 1.99 (s, 1H). Mass spectrum (ESI+): m/z (M + H)+ = 178. | [References]
[1] Bioorganic and Medicinal Chemistry, 2015, vol. 23, # 17, p. 5352 - 5359 [2] Journal of Medicinal Chemistry, 1998, vol. 41, # 12, p. 2146 - 2163 [3] Synthesis, 2005, # 16, p. 2751 - 2757 [4] Patent: WO2015/187934, 2015, A1. Location in patent: Paragraph 0228 |
|
|